This learning program is designed to introduce you to the disease state and clinical management of non-Hodgkin’s lymphoma.
Non-Hodgkin’s lymphoma is a heterogeneous group of neoplastic lymphatic disorders. Non-Hodgkin’s lymphoma accounts for about 4% of all cancers in the United States. It is the sixth most common malignancy in women and the seventh most common malignancy in men. An accurate diagnosis and staging of non-Hodgkin’s lymphoma determines the subtype, the extent of the disease, as well as the patient prognosis, and contritbutes to the optimal management of the disease.
The program begins with an insight into the characteristcs of non-Hodgkin’s lymphoma and its different types. You will learn about the risk factors, epidemiology, and pathophysiology of non-Hodgkin’s lymphoma. You will also learn about the clinical diagnosis of this disease and available treatment options.
Upon completion of this learning program, you will be able to::
Define non-Hodgkin’s lymphoma and its classes and subtypes.
Outline the incidence, prevalence, and risk factors of non-Hodgkin’s lymphoma.
Describe B-cell neoplasms.
Describe T-cell and natural killer-cell neoplasms.
Explain the procedures used to diagnose and evaluate non-Hodgkin’s lymphoma.
List the treatment options for non-Hodgkin’s lymphoma.
What Is Non-Hodgkin’s Lymphoma?
Types and Subtypes
The WHO Classification
Incidence and Prevalence
T-Cell and NK-Cell Neoplasms
National Comprehensive Cancer Network Guidelines
Test Your Acquired Knowledge
End of Program
This course is accredited for continuing education (CE) by the following organizations:
Australian Nursing & Midwifery Federation
CPD Hours: 1